Bayer’s Vividion Emerging as Significant Player in San Diego Biotech Hub

LEVERKUSEN, Germany & SAN DIEGO–(BUSINESS WIRE)–Bayer AG and its wholly owned San Diego-based subsidiary Vividion Therapeutics, Inc. (Vividion) will highlight how the two companies have fostered innovation and collaboration through Bayer’s “arm’s length” operating model during a presentation at the 2022 BIO International Convention. Bayer has built a strong partnership with Vividion since its acquisition of the biopharmaceutical company in 2021, deploying an innovative business model that all
Click here to view original post